Literature DB >> 16103589

The value of a new microculture method for diagnosis of visceral leishmaniasis by using bone marrow and peripheral blood.

Adil M Allahverdiyev1, Malahat Bagirova, Soner Uzun, Derya Alabaz, Necmi Aksaray, Emine Kocabas, Fatih Koksal.   

Abstract

We have demonstrated that the microculture method (MCM) enables the diagnosis of visceral leishmaniasis (VL) with samples from both the bone marrow (BM) and peripheral blood (PB). The MCM is superior to the traditional culture method (TCM) as determined by its higher sensitivity in the detection of promastigotes and the more rapid time for emergence of promastigotes. The sensitivity of MCM (100% in BMs and 77.8-100% in PB) was considerably higher than that of the TCM (37.5-100% in BMs and 0-100% in PB) according to decreasing parasite density (P < 0.05). The concentration of parasites in buffy coats has increased the sensitivity of both methods, especially that of the MCM. Detection of promastigotes by MCM requires lower amounts of culture media (25-50 microL) and shorter incubation periods (2-7 days) than TCM (2.5-3.5 mL and 15-35 days, respectively). MCM was found to be valuable with the advantages of simplicity and sensitivity, in addition to being cost-effective in the routine diagnosis for VL in Adana Turkey.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103589

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  8 in total

Review 1.  Diagnosis of visceral leishmaniasis: developments over the last decade.

Authors:  Gurumurthy Srividya; Arpita Kulshrestha; Ruchi Singh; Poonam Salotra
Journal:  Parasitol Res       Date:  2011-11-09       Impact factor: 2.289

2.  Utility of the microculture method in non-invasive samples obtained from an experimental murine model with asymptomatic leishmaniasis.

Authors:  Adil M Allahverdiyev; Malahat Bagirova; Rabia Cakir-Koc; Serhat Elcicek; Olga Nehir Oztel; Sezen Canim-Ates; Emrah Sefik Abamor; Serap Yesilkir-Baydar
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

3.  Isolation and diagnosis of Helicobacter pylori by a new method: microcapillary culture.

Authors:  Adil M Allahverdiyev; Melahat Bagirova; Reyhan Caliskan; Hrisi Bahar Tokman; Hayat Aliyeva; Gokce Unal; Olga Nehir Oztel; Emrah Sefik Abamor; Hilal Toptas; Pelin Yuksel; Fatma Kalayci; Mustafa Aslan; Yusuf Erzin; Kadir Bal; Bekir S Kocazeybek
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

4.  Ultrasensitive real-time PCR for the clinical management of visceral leishmaniasis in HIV-Infected patients.

Authors:  Israel Molina; Roser Fisa; Cristina Riera; Vicenç Falcó; Aleix Elizalde; Fernando Salvador; Manuel Crespo; Adrian Curran; Paulo López-Chejade; Silvia Tebar; Santiago Pérez-Hoyos; Esteban Ribera; Albert Pahissa
Journal:  Am J Trop Med Hyg       Date:  2013-04-29       Impact factor: 2.345

5.  Adipose tissue-derived mesenchymal stem cells as a new host cell in latent leishmaniasis.

Authors:  Adil M Allahverdiyev; Melahat Bagirova; Serhat Elcicek; Rabia Cakir Koc; Serap Yesilkir Baydar; Necati Findikli; Olga N Oztel
Journal:  Am J Trop Med Hyg       Date:  2011-09       Impact factor: 2.345

6.  Evaluation of a microculture method for isolation of Leishmania parasites from cutaneous lesions of patients in Peru.

Authors:  Andrea K Boggild; Cesar Miranda-Verastegui; Diego Espinosa; Jorge Arevalo; Vanessa Adaui; Gianfranco Tulliano; Alejandro Llanos-Cuentas; Donald E Low
Journal:  J Clin Microbiol       Date:  2007-09-19       Impact factor: 5.948

7.  Developments in diagnosis and antileishmanial drugs.

Authors:  Prachi Bhargava; Rajni Singh
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-18

8.  Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran.

Authors:  Mehdi Bamorovat; Iraj Sharifi; Mohammad Reza Aflatoonian; Hamid Sharifi; Ali Karamoozian; Fatemeh Sharifi; Ahmad Khosravi; Saeid Hassanzadeh
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.